Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: Implication for vaccination regimens [10]

T. M. Westers; J. J.W.M. Janssen; I. Houtenbos; N. C.L. Snoijs; A. A. van de Loosdrecht; G. J. Ossenkoppele

doi:10.1038/sj.leu.2404043

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: Implication for vaccination regimens [10]

T. M. Westers^*, J. J.W.M. Janssen, I. Houtenbos, N. C.L. Snoijs, A. A. van de Loosdrecht, G. J. Ossenkoppele

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	154-157
Number of pages	4
Journal	Leukemia
Volume	20
Issue number	1
DOIs	https://doi.org/10.1038/sj.leu.2404043
Publication status	Published - Jan 2006

Access to Document

10.1038/sj.leu.2404043

Cite this

@article{3ebe45fa3acd4ca695457f0d9ee8ca8a,

title = "Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: Implication for vaccination regimens [10]",

author = "Westers, {T. M.} and Janssen, {J. J.W.M.} and I. Houtenbos and Snoijs, {N. C.L.} and {van de Loosdrecht}, {A. A.} and Ossenkoppele, {G. J.}",

year = "2006",

month = jan,

doi = "10.1038/sj.leu.2404043",

language = "English",

volume = "20",

pages = "154--157",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate

T2 - Implication for vaccination regimens [10]

AU - Westers, T. M.

AU - Janssen, J. J.W.M.

AU - Houtenbos, I.

AU - Snoijs, N. C.L.

AU - van de Loosdrecht, A. A.

AU - Ossenkoppele, G. J.

PY - 2006/1

Y1 - 2006/1

UR - http://www.scopus.com/inward/record.url?scp=33644975906&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404043

DO - 10.1038/sj.leu.2404043

M3 - Letter

C2 - 16307013

AN - SCOPUS:33644975906

SN - 0887-6924

VL - 20

SP - 154

EP - 157

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of Imatinib mesylate: Implication for vaccination regimens [10]

Access to Document

Other files and links

Cite this